Screener
GoodRx Holdings, Inc. GDRX Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Other revenue | $3.88M-15.0% | $3.69M-15.8% | $4.16M-13.8% | $4.64M-14.0% | $4.56M-15.6% | |
| Pharma Direct revenue | $61.63M+76.2% | $52.23M+82.3% | —— | $43.37M+54.2% | $34.98M+32.0% | |
| Prescription transactions revenue | $106.39M-25.6% | $113.69M-23.7% | $124.72M-14.0% | $127.29M-9.3% | $143.06M-2.5% | |
| Subscription revenue | $28.51M+39.3% | $24.39M+16.1% | $21.52M+4.1% | $20.72M-2.7% | $20.46M-6.8% |
FAQ
- How does GoodRx Holdings, Inc. break its business down?
- GoodRx Holdings, Inc. (GDRX) reports revenue by product across 4 parts — Other revenue, Pharma Direct revenue, Prescription transactions revenue and Subscription revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does GoodRx Holdings, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in GoodRx Holdings, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
